Clorox Q3 Results Fall Short as Cost Pressures Weigh on Outlook
The Clorox Company (NYSE:CLX) reported fiscal third-quarter earnings on Thursday that missed revenue expectations, while the company cut its full-year profit forecast amid rising input costs and softening demand for cleaning products. Shares moved sharply lower in after-hours trading, reflecting investor disappointment.
Revenue and EPS: A Mixed Quarter Against Estimates
For the quarter ended March 31, Clorox posted net earnings of $1.64 per share on a non-GAAP basis, slightly above the analyst consensus estimate of $1.566. However, total revenue came in at $1.67 billion, falling short of the $1.683 billion analysts had penciled in.
This miss on the top line underscores a broader trend during the period: weaker demand for the company’s core cleaning and disinfecting products, particularly in the U.S. market. The revenue shortfall was not catastrophic—a gap of roughly 0.8%—but it comes amid a backdrop where pricing power and volume growth are increasingly strained.
Key Takeaways from the Press Release
The company also updated its outlook for the remainder of fiscal 2026. Management now sees full-year adjusted earnings per share in a lower range, citing:
- Elevated raw material and supply-chain costs tied to geopolitical tensions (the company referenced the impact of the U.S.-Israeli war on Iran raising costs).
- Softer consumer demand for certain cleaning and household products compared to earlier expectations.
While the company did not provide a specific updated EPS or sales target in the initial release, the downward revision signals that the operating environment has become more challenging than previously modeled. Analysts currently estimate full-year 2026 revenue of roughly $6.59 billion and EPS of $5.98, suggesting the company may struggle to hit the high end of those projections.
Market Reaction: A Clear Signal
The market’s reaction was decisive. Shares of Clorox fell approximately 3.6% in after-hours trading immediately following the release. Looking at recent performance, the stock has already been under pressure:
- Down roughly 2.1% over the past week
- Down about 7.9% over the past two weeks
- Down roughly 8.5% over the past month
The combination of a revenue miss and a cautious revised outlook has amplified selling pressure, especially given that Clorox is often viewed as a defensive consumer staples name. When even staple companies show signs of demand weakness and cost headwinds, investors tend to reassess valuations quickly.
Analyst Views
The consensus among analysts is now likely to shift toward greater caution. Despite the modest EPS beat, the revenue miss and lowered profit outlook are the dominant narratives. The next key test will be the fiscal fourth-quarter report, with analysts estimating revenue of $1.81 billion and EPS of $2.10. Achieving those numbers will depend heavily on whether cost pressures ease and whether consumer demand stabilizes.
Bottom Line
Clorox delivered EPS above expectations, but the more important metrics—revenue growth and forward guidance—disappointed. With costs rising and consumer demand cooling, the company is navigating a difficult environment. The after-market selloff reflects a market that is focused less on the headline earnings beat and more on the underlying headwinds.
For a deeper look at Clorox’s historical earnings results and to see future revenue and EPS projections, visit the company’s Earnings Page and Analyst Forecast Page.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. Always do your own research before making investment decisions.